Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii

Two obligate intracellular parasites, Trypanosoma cruzi, the agent of Chagas disease, and Toxoplasma gondii, an agent of toxoplasmosis, upregulate the mevalonate pathway of their host cells upon infection, which suggests that this host pathway could be a potential drug target. In this work, a number...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Szajnman, Sergio Hernán, Bonesi, Sergio Mauricio, Moreno, Silvia N. J., Rodríguez, Juan Bautista
Publicado: 2016
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18607179_v11_n24_p2690_Chao
http://hdl.handle.net/20.500.12110/paper_18607179_v11_n24_p2690_Chao
Aporte de:
id paper:paper_18607179_v11_n24_p2690_Chao
record_format dspace
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic antiprotozoal agents
drug discovery
enzymes
fluorine
inhibitors
2 acetoxy 4 phenoxyphenol
2 acetoxy 4 phenoxyphenoxyethanol
2 acetoxy 4 phenoxyphenoxyethyl 4 toluenesulfonate
2 acetoxy 4 phenoxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
2 acetoxy 4 phenoxyphenoxyethyl thiocyanate
3 (2 fluorophenoxy)phenoxyethanol
3 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (2 fluorophenoxy)phenoxyethyl thiocyanate
3 (3 fluorophenoxy)phenoxyethanol
3 (3 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (3 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (3 fluorophenoxy)phenoxyethyl thiocyanate
3 (4 fluorophenoxy)phenoxyethanol
3 (4 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (4 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl
3 (4 fluorophenoxy)phenoxyethyl thiocyanate
4 (2 fluorophenoxy)phenoxyethanol
4 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
4 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (2 fluorophenoxy)phenoxyethyl thiocyanate
4 (4 pyridyl)oxyphenoxyethanol
4 (4 pyridyl)oxyphenoxyethyl bromide
4 (4 pyridyl)oxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (4 pyridyl)oxyphenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
4 phenoxyphenyl acetate
fluorine derivative
squalene synthase inhibitor
unclassified drug
unindexed drug
4-phenoxyphenoxyethyl thiocyanate
antiparasitic agent
diphenyl ether derivative
fluorine
thiocyanic acid derivative
Article
controlled study
drug activity
drug design
drug potency
drug structure
drug synthesis
EC50
hydrogen bond
Michael addition
molecular dynamics
nonhuman
priority journal
Staudinger reaction
tissue culture cell
Toxoplasma gondii
Trypanosoma cruzi
Williamson reaction
animal
chemistry
Chlorocebus aethiops
computer simulation
drug effects
human
molecular model
sequence homology
Toxoplasma
Trypanosoma cruzi
Vero cell line
X ray crystallography
Animals
Antiparasitic Agents
Cercopithecus aethiops
Computer Simulation
Crystallography, X-Ray
Fluorine
Humans
Models, Molecular
Phenyl Ethers
Sequence Homology, Nucleic Acid
Thiocyanates
Toxoplasma
Trypanosoma cruzi
Vero Cells
spellingShingle antiprotozoal agents
drug discovery
enzymes
fluorine
inhibitors
2 acetoxy 4 phenoxyphenol
2 acetoxy 4 phenoxyphenoxyethanol
2 acetoxy 4 phenoxyphenoxyethyl 4 toluenesulfonate
2 acetoxy 4 phenoxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
2 acetoxy 4 phenoxyphenoxyethyl thiocyanate
3 (2 fluorophenoxy)phenoxyethanol
3 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (2 fluorophenoxy)phenoxyethyl thiocyanate
3 (3 fluorophenoxy)phenoxyethanol
3 (3 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (3 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (3 fluorophenoxy)phenoxyethyl thiocyanate
3 (4 fluorophenoxy)phenoxyethanol
3 (4 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (4 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl
3 (4 fluorophenoxy)phenoxyethyl thiocyanate
4 (2 fluorophenoxy)phenoxyethanol
4 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
4 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (2 fluorophenoxy)phenoxyethyl thiocyanate
4 (4 pyridyl)oxyphenoxyethanol
4 (4 pyridyl)oxyphenoxyethyl bromide
4 (4 pyridyl)oxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (4 pyridyl)oxyphenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
4 phenoxyphenyl acetate
fluorine derivative
squalene synthase inhibitor
unclassified drug
unindexed drug
4-phenoxyphenoxyethyl thiocyanate
antiparasitic agent
diphenyl ether derivative
fluorine
thiocyanic acid derivative
Article
controlled study
drug activity
drug design
drug potency
drug structure
drug synthesis
EC50
hydrogen bond
Michael addition
molecular dynamics
nonhuman
priority journal
Staudinger reaction
tissue culture cell
Toxoplasma gondii
Trypanosoma cruzi
Williamson reaction
animal
chemistry
Chlorocebus aethiops
computer simulation
drug effects
human
molecular model
sequence homology
Toxoplasma
Trypanosoma cruzi
Vero cell line
X ray crystallography
Animals
Antiparasitic Agents
Cercopithecus aethiops
Computer Simulation
Crystallography, X-Ray
Fluorine
Humans
Models, Molecular
Phenyl Ethers
Sequence Homology, Nucleic Acid
Thiocyanates
Toxoplasma
Trypanosoma cruzi
Vero Cells
Szajnman, Sergio Hernán
Bonesi, Sergio Mauricio
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
topic_facet antiprotozoal agents
drug discovery
enzymes
fluorine
inhibitors
2 acetoxy 4 phenoxyphenol
2 acetoxy 4 phenoxyphenoxyethanol
2 acetoxy 4 phenoxyphenoxyethyl 4 toluenesulfonate
2 acetoxy 4 phenoxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
2 acetoxy 4 phenoxyphenoxyethyl thiocyanate
3 (2 fluorophenoxy)phenoxyethanol
3 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (2 fluorophenoxy)phenoxyethyl thiocyanate
3 (3 fluorophenoxy)phenoxyethanol
3 (3 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (3 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
3 (3 fluorophenoxy)phenoxyethyl thiocyanate
3 (4 fluorophenoxy)phenoxyethanol
3 (4 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
3 (4 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl
3 (4 fluorophenoxy)phenoxyethyl thiocyanate
4 (2 fluorophenoxy)phenoxyethanol
4 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate
4 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (2 fluorophenoxy)phenoxyethyl thiocyanate
4 (4 pyridyl)oxyphenoxyethanol
4 (4 pyridyl)oxyphenoxyethyl bromide
4 (4 pyridyl)oxyphenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (4 pyridyl)oxyphenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
4 phenoxyphenyl acetate
fluorine derivative
squalene synthase inhibitor
unclassified drug
unindexed drug
4-phenoxyphenoxyethyl thiocyanate
antiparasitic agent
diphenyl ether derivative
fluorine
thiocyanic acid derivative
Article
controlled study
drug activity
drug design
drug potency
drug structure
drug synthesis
EC50
hydrogen bond
Michael addition
molecular dynamics
nonhuman
priority journal
Staudinger reaction
tissue culture cell
Toxoplasma gondii
Trypanosoma cruzi
Williamson reaction
animal
chemistry
Chlorocebus aethiops
computer simulation
drug effects
human
molecular model
sequence homology
Toxoplasma
Trypanosoma cruzi
Vero cell line
X ray crystallography
Animals
Antiparasitic Agents
Cercopithecus aethiops
Computer Simulation
Crystallography, X-Ray
Fluorine
Humans
Models, Molecular
Phenyl Ethers
Sequence Homology, Nucleic Acid
Thiocyanates
Toxoplasma
Trypanosoma cruzi
Vero Cells
description Two obligate intracellular parasites, Trypanosoma cruzi, the agent of Chagas disease, and Toxoplasma gondii, an agent of toxoplasmosis, upregulate the mevalonate pathway of their host cells upon infection, which suggests that this host pathway could be a potential drug target. In this work, a number of compounds structurally related to WC-9 (4-phenoxyphenoxyethyl thiocyanate), a known squalene synthase inhibitor, were designed, synthesized, and evaluated for their effect on T. cruzi and T. gondii growth in tissue culture cells. Two fluorine-containing derivatives, the 3-(3-fluorophenoxy)- and 3-(4-fluorophenoxy)phenoxyethyl thiocyanates, exhibited half-maximal effective concentration (EC50) values of 1.6 and 4.9 μm, respectively, against tachyzoites of T. gondii, whereas they showed similar potency to WC-9 against intracellular T. cruzi (EC50values of 5.4 and 5.7 μm, respectively). In addition, 2-[3- (phenoxy)phenoxyethylthio]ethyl-1,1-bisphosphonate, which is a hybrid inhibitor containing 3-phenoxyphenoxy and bisphosphonate groups, has activity against T. gondii proliferation at sub-micromolar levels (EC50=0.7 μm), which suggests a combined inhibitory effect of the two functional groups. © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
author Szajnman, Sergio Hernán
Bonesi, Sergio Mauricio
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
author_facet Szajnman, Sergio Hernán
Bonesi, Sergio Mauricio
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
author_sort Szajnman, Sergio Hernán
title Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
title_short Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
title_full Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
title_fullStr Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
title_full_unstemmed Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii
title_sort activity of fluorine-containing analogues of wc-9 and structurally related analogues against two intracellular parasites: trypanosoma cruzi and toxoplasma gondii
publishDate 2016
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18607179_v11_n24_p2690_Chao
http://hdl.handle.net/20.500.12110/paper_18607179_v11_n24_p2690_Chao
work_keys_str_mv AT szajnmansergiohernan activityoffluorinecontaininganaloguesofwc9andstructurallyrelatedanaloguesagainsttwointracellularparasitestrypanosomacruziandtoxoplasmagondii
AT bonesisergiomauricio activityoffluorinecontaininganaloguesofwc9andstructurallyrelatedanaloguesagainsttwointracellularparasitestrypanosomacruziandtoxoplasmagondii
AT morenosilvianj activityoffluorinecontaininganaloguesofwc9andstructurallyrelatedanaloguesagainsttwointracellularparasitestrypanosomacruziandtoxoplasmagondii
AT rodriguezjuanbautista activityoffluorinecontaininganaloguesofwc9andstructurallyrelatedanaloguesagainsttwointracellularparasitestrypanosomacruziandtoxoplasmagondii
_version_ 1768543007682854912
spelling paper:paper_18607179_v11_n24_p2690_Chao2023-06-08T16:29:28Z Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii Szajnman, Sergio Hernán Bonesi, Sergio Mauricio Moreno, Silvia N. J. Rodríguez, Juan Bautista antiprotozoal agents drug discovery enzymes fluorine inhibitors 2 acetoxy 4 phenoxyphenol 2 acetoxy 4 phenoxyphenoxyethanol 2 acetoxy 4 phenoxyphenoxyethyl 4 toluenesulfonate 2 acetoxy 4 phenoxyphenoxyethyl tetrahydro 2h pyran 2 yl ether 2 acetoxy 4 phenoxyphenoxyethyl thiocyanate 3 (2 fluorophenoxy)phenoxyethanol 3 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate 3 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether 3 (2 fluorophenoxy)phenoxyethyl thiocyanate 3 (3 fluorophenoxy)phenoxyethanol 3 (3 fluorophenoxy)phenoxyethyl 4 toluenesulfonate 3 (3 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether 3 (3 fluorophenoxy)phenoxyethyl thiocyanate 3 (4 fluorophenoxy)phenoxyethanol 3 (4 fluorophenoxy)phenoxyethyl 4 toluenesulfonate 3 (4 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl 3 (4 fluorophenoxy)phenoxyethyl thiocyanate 4 (2 fluorophenoxy)phenoxyethanol 4 (2 fluorophenoxy)phenoxyethyl 4 toluenesulfonate 4 (2 fluorophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether 4 (2 fluorophenoxy)phenoxyethyl thiocyanate 4 (4 pyridyl)oxyphenoxyethanol 4 (4 pyridyl)oxyphenoxyethyl bromide 4 (4 pyridyl)oxyphenoxyethyl tetrahydro 2h pyran 2 yl ether 4 (4 pyridyl)oxyphenoxyethyl thiocyanate 4 phenoxyphenoxyethyl thiocyanate 4 phenoxyphenyl acetate fluorine derivative squalene synthase inhibitor unclassified drug unindexed drug 4-phenoxyphenoxyethyl thiocyanate antiparasitic agent diphenyl ether derivative fluorine thiocyanic acid derivative Article controlled study drug activity drug design drug potency drug structure drug synthesis EC50 hydrogen bond Michael addition molecular dynamics nonhuman priority journal Staudinger reaction tissue culture cell Toxoplasma gondii Trypanosoma cruzi Williamson reaction animal chemistry Chlorocebus aethiops computer simulation drug effects human molecular model sequence homology Toxoplasma Trypanosoma cruzi Vero cell line X ray crystallography Animals Antiparasitic Agents Cercopithecus aethiops Computer Simulation Crystallography, X-Ray Fluorine Humans Models, Molecular Phenyl Ethers Sequence Homology, Nucleic Acid Thiocyanates Toxoplasma Trypanosoma cruzi Vero Cells Two obligate intracellular parasites, Trypanosoma cruzi, the agent of Chagas disease, and Toxoplasma gondii, an agent of toxoplasmosis, upregulate the mevalonate pathway of their host cells upon infection, which suggests that this host pathway could be a potential drug target. In this work, a number of compounds structurally related to WC-9 (4-phenoxyphenoxyethyl thiocyanate), a known squalene synthase inhibitor, were designed, synthesized, and evaluated for their effect on T. cruzi and T. gondii growth in tissue culture cells. Two fluorine-containing derivatives, the 3-(3-fluorophenoxy)- and 3-(4-fluorophenoxy)phenoxyethyl thiocyanates, exhibited half-maximal effective concentration (EC50) values of 1.6 and 4.9 μm, respectively, against tachyzoites of T. gondii, whereas they showed similar potency to WC-9 against intracellular T. cruzi (EC50values of 5.4 and 5.7 μm, respectively). In addition, 2-[3- (phenoxy)phenoxyethylthio]ethyl-1,1-bisphosphonate, which is a hybrid inhibitor containing 3-phenoxyphenoxy and bisphosphonate groups, has activity against T. gondii proliferation at sub-micromolar levels (EC50=0.7 μm), which suggests a combined inhibitory effect of the two functional groups. © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Fil:Szajnman, S.H. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Bonesi, S.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Moreno, S.N.J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rodriguez, J.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2016 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18607179_v11_n24_p2690_Chao http://hdl.handle.net/20.500.12110/paper_18607179_v11_n24_p2690_Chao